Featured News

 

Latest News

ID Genomics Launches National Consortorium
ID Genomics Launches National Consortorium
News   Jan 18, 2017

The consortium will bring together a number of clinical partners to help improve the diagnosis of infectious diseases and appropriate use of antibiotics.

READ MORE

New Insights Into Cognitive Disorders
New Insights Into Cognitive Disorders
News   Jan 18, 2017

A study of 35,000 people has revealed new genetic variations related to cognitive ability providing new hope for the treatment of cognitive disorders of the brain.

READ MORE

Tempus, Seidman Cancer Center Partner Up
Tempus, Seidman Cancer Center Partner Up
News   Jan 18, 2017

Collaboration is to focus on improving research and healthcare by improving the use and analysis of genomic data.

READ MORE

A Knowledge Bank to Inform Personalised Cancer Treatment
A Knowledge Bank to Inform Personalised Cancer Treatment
News   Jan 18, 2017

A proof-of-concept study using data from 1540 AML patients shows that truly personalised cancer therapy will be possible in the future.

READ MORE

Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
News   Jan 18, 2017

Pall ForteBio will acquire the assets related to SensiQ's Pioneer product line.

READ MORE

Domainex Improves Fragment Based Drug Discovery Services
Domainex Improves Fragment Based Drug Discovery Services
News   Jan 18, 2017

Addition of Monolith NT from NanoTemper Technologies Ltd. enables Domainex to offer a unique protein production, characterisation, and fragment screening service.

READ MORE

X-Chem and Taiho Pharmaceuticals Collaborate
X-Chem and Taiho Pharmaceuticals Collaborate
News   Jan 18, 2017

The collaboration will grant Taiho access to X-Chem’s DEX™ technology which is based on DNA-encoded libraries of small molecules with more than 120 billion molecules.

READ MORE

Mouse ES Cells Reprogrammed to be Totipotent-like
Mouse ES Cells Reprogrammed to be Totipotent-like
News   Jan 17, 2017

Scientists from UC Berkeley have shown that miR-34a plays an important regulatory role in stem cell fate.

READ MORE

Horizon Broadens Industry-leading Gene Editing Capabilities
Horizon Broadens Industry-leading Gene Editing Capabilities
News   Jan 17, 2017

£523,000 provided to Horizon through Innovate UK grant for the development of an automated gene-editing platform.

READ MORE

Epigenetic Modification Linked to Throat Cancer
Epigenetic Modification Linked to Throat Cancer
News   Jan 17, 2017

Discovery could improve care for around 15% of adult head and neck cancer patients.

READ MORE